Insider Trading History of Krivulka Joseph J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Krivulka Joseph J since 2008. The trader's CIK number is 1296750. At the time of the last reporting, Krivulka Joseph J was the Director of Nektar Therapeutics. (stock ticker symbol NKTR). Also see all insider trading activities at Nektar Therapeutics.

Note that in the past Krivulka Joseph J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aeolus Pharmaceuticals, Inc. (AOLS) by Krivulka Joseph J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 AOLS 400,000 $0 0 $0 0 $0
2012 AOLS 333,333 $99,999 0 $0 0 $0

Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Krivulka Joseph J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 NKTR 0 $0 0 $0 15,000 $125,549
2016 NKTR 0 $0 0 $0 15,000 $0
2015 NKTR 0 $0 0 $0 15,000 $132,150
2011 NKTR 0 $0 0 $0 10,000 $0
2008 NKTR 0 $0 0 $0 5,000 $0


Insider trading activities at 2 companies by Krivulka Joseph J:

1. Aeolus Pharmaceuticals, Inc. (AOLS)

2. Nektar Therapeutics (NKTR)

Table 1. Insider trading of Aeolus Pharmaceuticals, Inc. (AOLS) by Krivulka Joseph J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-02-19 AOLS Buy 400,000 .00 0
2012-04-05 AOLS Buy 333,333 .30 99,999

Table 2. Insider trading of Nektar Therapeutics (NKTR) by Krivulka Joseph J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-06-26 NKTR Option Ex 15,000 8.37 125,549
2016-09-15 NKTR Option Ex 15,000 .00 0
2015-07-24 NKTR Option Ex 15,000 8.81 132,150
2011-03-07 NKTR Option Ex 10,000 .00 0
2008-11-14 NKTR Option Ex 5,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krivulka Joseph J (Director of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.